These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23144930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers.
    Egeland NG, Jonsdottir K, Aure MR, Sahlberg K, Kristensen VN, Cronin-Fenton D, Skaland I, Gudlaugsson E, Baak JPA, Janssen EAM.
    BMC Cancer; 2020 May 05; 20(1):377. PubMed ID: 32370743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients.
    Liu K, Pan X, Peng X, Zhang C, Li H, Guan X, Xu W, Xu J, Zhao L, Wang T, Lai Y.
    Pathol Res Pract; 2019 Jun 05; 215(6):152391. PubMed ID: 31076282
    [Abstract] [Full Text] [Related]

  • 7. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
    Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R.
    Diagn Pathol; 2012 Mar 22; 7():31. PubMed ID: 22439831
    [Abstract] [Full Text] [Related]

  • 8. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 22; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
    Quesne JL, Jones J, Warren J, Dawson SJ, Ali HR, Bardwell H, Blows F, Pharoah P, Caldas C.
    J Pathol; 2012 Jul 22; 227(3):306-14. PubMed ID: 22294324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
    Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW.
    Proc Natl Acad Sci U S A; 2008 Sep 02; 105(35):13021-6. PubMed ID: 18755890
    [Abstract] [Full Text] [Related]

  • 14. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F, Mowla SJ, Honardoost MA, Arjenaki MG, Moazeni-Bistgani M, Kheiri S, Teimori H.
    Tumour Biol; 2017 Aug 02; 39(8):1010428317698362. PubMed ID: 28857013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X, Wang YW, Zhu WJ, Li Y, Liu L, Yin G, Gao P.
    Hum Pathol; 2018 Jun 02; 76():122-132. PubMed ID: 29555574
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
    Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H.
    Breast Cancer Res Treat; 2011 Nov 02; 130(1):331-9. PubMed ID: 21755340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.